Merck filed for approval of gefapixant in March 2021 on the strength of a pair of phase 3 trials – COUGH-1 and COUGH-2 – which found that the drug reduced 24-hour cough frequency by 18% and 15 ...

Bayer says its drug candidate for chronic cough – eliapixant – has hit the mark in a phase 2b trial, putting it in hot pursuit of Merck & Co's gefapixant, which was filed for approval in March.

At Senate HELP committee, lawmakers grill Robert F. Kennedy Jr. on his record of vaccine skepticism and thoughts on ...

Did RFK Jr.'s long-record of anti-vaccine activism affect his chances at becoming Trump's secretary of health?

But Merck's which is also P2X3 ... we expect around just under 3 million patients in the U.S. will have had chronic cough for more than a year. And actually over that number in Europe.

Kennedy has linked the rise of chronic disease, autism and food allergies ... diseases he has lived through - he contracted whooping cough and was hospitalized as a result of influenza as a ...

Kennedy has linked the rise of chronic disease, autism and food allergies in the United ... the scourge of diseases he has lived through — he contracted whooping cough and was hospitalized as a result ...

Increase in ER Visits, Hospital Admissions is Driven by Flu; IDPH Urges Public To Quickly Seek Testing and Treatment if they Experience Flu-like Symptoms The Illinois Department of Public Health (IDPH ...

The Illinois Department of Public Health (IDPH) announced that in line with the national trend, the state’s overall respiratory illness level has ticked up from Moderate to High, driven by ...